ACAD — Acadia Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapFalling Star

Annual balance sheet for Acadia Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	697	632	521	417	439
Net Total Accounts Receivable
Net Total Receivables	37.9	50.3	65.3	63.1	102
Total Inventory
Prepaid Expenses
Total Current Assets	760	718	618	508	616
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	12.7	56.4	66.3	61.6	56.5
Net Intangible Assets
Other Long Term Assets
Total Assets	783	783	700	588	749
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	74.8	106	96.1	126	254
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	84	156	159	187	317
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	699	627	541	400	432
Total Liabilities & Shareholders' Equity	783	783	700	588	749
Total Common Shares Outstanding